372P Treatment patterns and outcomes in stage III non-small cell lung cancer (NSCLC): Real-world experience in Singapore from the KINDLE study
Sign Up to like & getrecommendations! Published in 2020 at "Annals of Oncology"
DOI: 10.1016/j.annonc.2020.10.365
Abstract: K. Prabhash, A.R. Jazieh, H.C. Onal, D.S. Weng Tan, R.A. Soo, A. Kumar, R. Huggenberger, S. Robb, B.C. Cho Medical Onclogy Department, Tata Memorial Hospital, Mumbai, India; Department of Oncology, King Abdullah International Medical Research… read more here.
Keywords: cancer; 372p treatment; treatment patterns; oncology ... See more keywords
Clinical characteristics and surgical outcomes in stage 4 macular hole with epiretinal proliferation.
Sign Up to like & getrecommendations! Published in 2023 at "Retina"
DOI: 10.1097/iae.0000000000003848
Abstract: PURPOSE To investigate the clinical characteristics and surgical outcomes of stage 4 macular holes (MHs) with epiretinal proliferation (EP) and explore the pathogenesis of MH formation. METHODS This retrospective study included consecutive patients who underwent… read more here.
Keywords: epiretinal proliferation; stage macular; surgical outcomes; characteristics surgical ... See more keywords
Adjuvant therapy use and outcomes of stage II and III colorectal cancer (CRC): Comparison of young and elderly patients (pts) in a large, contemporary, population-based Canadian database.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.4_suppl.807
Abstract: 807Background: The incidence of CRC increases significantly with age. Despite the benefits associated with adjuvant therapy, older pts are frequently treated less aggressively due to perceived poor... read more here.
Keywords: use outcomes; outcomes stage; crc; therapy use ... See more keywords
Outcomes of stage IV melanoma in the era of immunotherapy (IO): A National Cancer Database (NCDB) analysis.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.e21520
Abstract: e21520 Background: The majority of data for IO in melanoma stems from trials that have specific inclusion criteria and often exclude important populations. In this analysis, we present the first real-world evidence of outcomes for… read more here.
Keywords: outcomes stage; 2015 2017; 2011 2014; stage melanoma ... See more keywords